GMO Research & AI 대차 대조표 상태

재무 상태 기준 확인 6/6

GMO Research & AI 의 총 주주 지분은 ¥1.9B 이고 총 부채는 ¥0.0, 이는 부채 대 자기자본 비율을 0% 로 가져옵니다. 총자산과 총부채는 각각 ¥2.7B 및 ¥821.0M 입니다. GMO Research & AI 의 EBIT는 ¥212.0M 이며 이자보상배율은 -14.1 입니다. ¥1.2B 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

부채 비율

JP¥0

부채

이자 보상 비율	-14.1x
현금	JP¥1.16b
주식	JP¥1.93b
총 부채	JP¥821.00m
총 자산	JP¥2.75b

최근 재무 상태 업데이트

업데이트 없음

Recent updates

Investors Can Find Comfort In GMO Research & AI's (TSE:3695) Earnings Quality

Aug 22

GMO Research & AI, Inc. (TSE:3695) Investors Are Less Pessimistic Than Expected

Aug 07

재무 상태 분석

단기부채: 3695 의 단기 자산 ( ¥2.1B )이 단기 부채( ¥805.0M ).

장기 부채: 3695 의 단기 자산( ¥2.1B )이 장기 부채( ¥16.0M ).

부채 대 자본 내역 및 분석

부채 수준: 3695 부채가 없습니다.

부채 감소: 3695 지난 5년간 부채가 없습니다.

부채 범위: 3695 은 부채가 없으므로 영업현금흐름으로 충당할 필요가 없습니다.

이자 보장: 3695 에는 부채가 없으므로 이자 지불에 대한 보장은 문제가 되지 않습니다.

GMO Research & AI 대차 대조표 상태

재무 상태 기준 확인 6/6

주요 정보

최근 재무 상태 업데이트

Recent updates

Third quarter 2024 earnings released: JP¥8.57 loss per share (vs JP¥38.59 profit in 3Q 2023)

GMO Research & AI, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Investors Can Find Comfort In GMO Research & AI's (TSE:3695) Earnings Quality

Second quarter 2024 earnings released: JP¥12.24 loss per share (vs JP¥11.64 profit in 2Q 2023)

GMO Research & AI, Inc. (TSE:3695) Investors Are Less Pessimistic Than Expected

Investor sentiment deteriorates as stock falls 21%

GMO Research & AI, Inc. to Report Q2, 2024 Results on Aug 06, 2024

First quarter 2024 earnings released: EPS: JP¥56.31 (vs JP¥82.69 in 1Q 2023)

GMO Research, Inc. to Report Q1, 2024 Results on May 08, 2024

Full year 2023 earnings released: EPS: JP¥188 (vs JP¥218 in FY 2022)

GMO Research, Inc., Annual General Meeting, Mar 18, 2024

GMO Research, Inc. to Report Fiscal Year 2023 Results on Feb 05, 2024

Upcoming dividend of JP¥115 per share at 4.0% yield

Third quarter 2023 earnings released: EPS: JP¥38.59 (vs JP¥44.12 in 3Q 2022)

GMO Research, Inc. to Report Q3, 2023 Results on Nov 06, 2023

New major risk - Earnings quality

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: JP¥11.64 (vs JP¥43.51 in 2Q 2022)

GMO Research, Inc. to Report Q2, 2023 Results on Aug 03, 2023

First quarter 2023 earnings released: EPS: JP¥82.69 (vs JP¥107 in 1Q 2022)

Full year 2022 earnings released: EPS: JP¥218 (vs JP¥168 in FY 2021)

Investor sentiment deteriorates as stock falls 15%

Full year 2022 earnings released: EPS: JP¥218 (vs JP¥168 in FY 2021)

GMO Research, Inc., Annual General Meeting, Mar 22, 2023

Upcoming dividend of JP¥116 per share

GMO Research, Inc. to Report Fiscal Year 2022 Results on Feb 06, 2023

No independent directors

Third quarter 2022 earnings released: EPS: JP¥44.12 (vs JP¥28.82 in 3Q 2021)

GMO Research, Inc. to Report Q3, 2022 Results on Nov 07, 2022

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: EPS: JP¥43.51 (vs JP¥14.11 in 2Q 2021)

GMO Research, Inc. to Report Q2, 2022 Results on Aug 04, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

GMO Research, Inc. to Report Q1, 2022 Results on May 09, 2022

First quarter 2022 earnings released: EPS: JP¥107 (vs JP¥64.39 in 1Q 2021)

No independent directors

GMO Research, Inc., Annual General Meeting, Mar 18, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of JP¥73.53 per share

Third quarter 2021 earnings released: EPS JP¥28.82 (vs JP¥25.76 in 3Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS JP¥64.39 (vs JP¥19.01 in 1Q 2020)

Investor sentiment improved over the past week

GMO Research, Inc. to launch new service brand “MO Lite”

GMO Research, Inc., Annual General Meeting, Mar 19, 2021

Full year 2020 earnings released: EPS JP¥107 (vs JP¥83.74 in FY 2019)

New 90-day low: JP¥1,645

GMO Research, Inc. to Report Q3, 2020 Results on Nov 06, 2020

GMO Research, Inc. to Report Q2, 2020 Results on Aug 07, 2020

재무 상태 분석

부채 대 자본 내역 및 분석

대차 대조표

건강한 기업 발견하기